Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 CAD | -10.00% | -35.71% | -59.09% |
06-07 | Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD | CI |
05-31 | Transcript : Numinus Wellness Inc. - Shareholder/Analyst Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.09% | 11.65M | |
+47.69% | 57.87B | |
+41.65% | 40.25B | |
-6.96% | 39.94B | |
-5.96% | 28.54B | |
+12.07% | 26.4B | |
-20.54% | 19.33B | |
+30.17% | 12.4B | |
-0.73% | 12.23B | |
+24.01% | 12.2B |
- Stock Market
- Equities
- NUMI Stock
- News Numinus Wellness Inc.
- Numinus Wellness Brief: Appointing Nikhil Handa as Chief Financial Officer, effective June 15, 2023, following an executive search; Current CFO, John Fong, will be stepping down effective end of day today to focus on family health matters